1. Home
  2. PRLD vs HUHU Comparison

PRLD vs HUHU Comparison

Compare PRLD & HUHU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRLD
  • HUHU
  • Stock Information
  • Founded
  • PRLD 2016
  • HUHU 2015
  • Country
  • PRLD United States
  • HUHU China
  • Employees
  • PRLD N/A
  • HUHU N/A
  • Industry
  • PRLD Medicinal Chemicals and Botanical Products
  • HUHU
  • Sector
  • PRLD Health Care
  • HUHU
  • Exchange
  • PRLD Nasdaq
  • HUHU NYSE
  • Market Cap
  • PRLD 73.7M
  • HUHU 86.8M
  • IPO Year
  • PRLD 2020
  • HUHU 2024
  • Fundamental
  • Price
  • PRLD $1.05
  • HUHU $4.51
  • Analyst Decision
  • PRLD Strong Buy
  • HUHU
  • Analyst Count
  • PRLD 2
  • HUHU 0
  • Target Price
  • PRLD $4.50
  • HUHU N/A
  • AVG Volume (30 Days)
  • PRLD 611.2K
  • HUHU 60.0K
  • Earning Date
  • PRLD 02-13-2025
  • HUHU 02-22-2025
  • Dividend Yield
  • PRLD N/A
  • HUHU N/A
  • EPS Growth
  • PRLD N/A
  • HUHU 13.14
  • EPS
  • PRLD N/A
  • HUHU 0.08
  • Revenue
  • PRLD $3,000,000.00
  • HUHU $17,492,735.00
  • Revenue This Year
  • PRLD N/A
  • HUHU N/A
  • Revenue Next Year
  • PRLD N/A
  • HUHU N/A
  • P/E Ratio
  • PRLD N/A
  • HUHU $54.80
  • Revenue Growth
  • PRLD N/A
  • HUHU 33.03
  • 52 Week Low
  • PRLD $0.80
  • HUHU $3.52
  • 52 Week High
  • PRLD $6.80
  • HUHU $9.89
  • Technical
  • Relative Strength Index (RSI)
  • PRLD 45.27
  • HUHU N/A
  • Support Level
  • PRLD $0.98
  • HUHU N/A
  • Resistance Level
  • PRLD $1.43
  • HUHU N/A
  • Average True Range (ATR)
  • PRLD 0.12
  • HUHU 0.00
  • MACD
  • PRLD -0.02
  • HUHU 0.00
  • Stochastic Oscillator
  • PRLD 14.14
  • HUHU 0.00

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

About HUHU HUHUTECH INTL GROUP INC

HUHUTECH International Group Inc specializes in providing factory facility management and monitoring systems, including high-purity gas, chemicals and liquid system and factory management and control systems for industrial clients, who are mainly semi-conductor manufacturers and electronics manufacturers in China. The products and services are widely used by semi-conductor manufacturers, LED and micro-electronics factories, as well as some pharmaceutical, food and beverage manufacturers.

Share on Social Networks: